Vera Therapeutics Inc (VERA) Insider Trading
- $50,393,898.11
- $52,801,627.73
- April 14, 2026
- Marshall Fordyce
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| April 14, 2026 | CEO | 22,951 | $44.05 | Sell | $1,010,991.55 | |
| Feb. 23, 2026 | Insider | 2,187 | $41.98 | Sell | $91,810.26 | |
| Feb. 23, 2026 | CFO | 4,949 | $41.98 | Sell | $207,759.02 | |
| Feb. 23, 2026 | Insider | 2,151 | $41.98 | Sell | $90,298.98 | |
| Feb. 23, 2026 | CEO | 16,925 | $41.98 | Sell | $710,511.50 | |
| Feb. 23, 2026 | Insider | 1,582 | $41.98 | Sell | $66,412.36 | |
| Feb. 23, 2026 | COO | 2,579 | $41.98 | Sell | $108,266.42 | |
| Feb. 23, 2026 | SVP | 3,117 | $41.98 | Sell | $130,851.66 | |
| June 24, 2025 | Director | 40,607 | $22.35 | Buy | $907,566.45 | |
| June 23, 2025 | Director | 209,393 | $20.87 | Buy | $4,370,031.91 | |
| Jan. 8, 2025 | CEO | 17,500 | $41.74 | Sell | $730,450.00 | |
| Dec. 18, 2024 | CEO | 17,500 | $43.07 | Sell | $753,725.00 | |
| Dec. 11, 2024 | CEO | 17,500 | $46.94 | Sell | $821,450.00 | |
| Oct. 28, 2024 | Director | 15,000 | $48.03 | Sell | $720,450.00 | |
| Oct. 23, 2024 | CEO | 19,375 | $40.39 | Sell | $782,556.25 | |
| Oct. 9, 2024 | CEO | 15,625 | $38.24 | Sell | $597,500.00 | |
| Sept. 25, 2024 | CEO | 23,125 | $46.05 | Sell | $1,064,906.25 | |
| Sept. 18, 2024 | Director | 1,177 | $42.01 | Sell | $49,445.77 | |
| Sept. 11, 2024 | CEO | 15,625 | $37.50 | Sell | $585,937.50 | |
| Aug. 21, 2024 | CEO | 14,471 | $39.76 | Sell | $575,366.96 | |
| April 10, 2024 | SVP | 5,714 | $40.00 | Sell | $228,560.00 | |
| April 3, 2024 | CFO | 99,828 | $39.61 | Sell | $3,954,187.08 | |
| March 25, 2024 | Director | 340,000 | $40.50 | Sell | $13,770,000.00 | |
| March 21, 2024 | Director | 81,009 | $44.20 | Sell | $3,580,597.80 | |
| Jan. 30, 2024 | Director | 161,290 | $31.00 | Buy | $4,999,990.00 | |
| Jan. 10, 2024 | Major Shareholder | 1,050,000 | $18.00 | Sell | $18,900,000.00 | |
| Aug. 21, 2023 | Insider | 1,490 | $16.65 | Sell | $24,808.50 | |
| Aug. 21, 2023 | CEO | 5,210 | $16.66 | Sell | $86,798.60 | |
| June 23, 2023 | CFO | 5,000 | $16.60 | Buy | $83,000.00 | |
| June 20, 2023 | Major Shareholder | 448,217 | $15.17 | Buy | $6,799,451.89 | |
| March 30, 2023 | Director | 2,300 | $7.24 | Buy | $16,652.00 | |
| March 27, 2023 | Director | 1,633 | $7.24 | Buy | $11,822.92 | |
| March 24, 2023 | Director | 1,833 | $7.24 | Buy | $13,270.92 | |
| March 20, 2023 | Director | 15,252 | $7.21 | Buy | $109,966.92 | |
| March 17, 2023 | Director | 74,045 | $7.12 | Buy | $527,200.40 | |
| March 15, 2023 | Director | 32,844 | $7.12 | Buy | $233,849.28 | |
| March 10, 2023 | Director | 48,003 | $7.16 | Buy | $343,701.48 | |
| March 3, 2023 | Director | 1,000 | $7.25 | Buy | $7,250.00 | |
| March 1, 2023 | Director | 100 | $7.25 | Buy | $725.00 | |
| Feb. 23, 2023 | Director | 200 | $7.24 | Buy | $1,448.00 | |
| Feb. 13, 2023 | Director | 10,072 | $7.20 | Buy | $72,518.40 | |
| Feb. 8, 2023 | Director | 45,357 | $7.22 | Buy | $327,477.54 | |
| Feb. 6, 2023 | Director | 1,714,285 | $7.00 | Buy | $11,999,995.00 | |
| Feb. 6, 2023 | Major Shareholder | 285,714 | $7.00 | Buy | $1,999,998.00 | |
| Dec. 16, 2022 | Insider | 2,212 | $19.49 | Sell | $43,111.88 | |
| Nov. 17, 2022 | Insider | 3,289 | $15.85 | Sell | $52,130.65 | |
| Oct. 18, 2022 | Insider | 8,590 | $19.41 | Sell | $166,731.90 | |
| Oct. 5, 2022 | Insider | 988 | $21.64 | Sell | $21,380.32 | |
| Oct. 4, 2022 | CEO | 18,223 | $21.19 | Sell | $386,145.37 | |
| Sept. 20, 2022 | Insider | 15,666 | $20.67 | Sell | $323,816.22 |
Insiders are both buying and selling Vera Therapeutics Inc stock.
The insider traders at Vera Therapeutics Inc are: Marshall Fordyce, Beth C Seidenberg, Joanne Curley, Patrick G Enright, Sean Grant, Maha Katabi, Commodore Capital Lp, Sofinnova Venture Partners X,, Joseph R Young, Curley Joanne, William D Turner, Carlyle Group Inc., Celia Lin, David Lee Johnson, Laurence Matthew Skelton, Llp Abingworth, and Robert Brenner
The most active insider trader at Vera Therapeutics Inc is Marshall Fordyce with 15 trades.
Commodore Capital Lp has sold the most Vera Therapeutics Inc stock with a total value of $37,800,000.00.
Patrick G Enright has bought the most Vera Therapeutics Inc stock with a total value of $23,185,154.81.
The most recent insider trade for Vera Therapeutics Inc was on April 14, 2026.
The single biggest insider buy for Vera Therapeutics Inc was from Patrick G Enright with a total value of $11,999,995.00 on Feb. 6, 2023.
The single biggest insider sell for Vera Therapeutics Inc was from Commodore Capital Lp with a total value of $18,900,000.00 on Jan. 10, 2024.
